Sprowl JA - Search Results

1

Uptake carriers and oncology drug safety.

Sprowl JA, Sparreboom A. Sprowl JA, et al. Drug Metab Dispos. 2014 Apr;42(4):611-22. doi: 10.1124/dmd.113.055806. Epub 2013 Dec 30. Drug Metab Dispos. 2014. PMID: 24378324 Free PMC article. Review.

2

Contribution of tumoral and host solute carriers to clinical drug response.

Sprowl JA, Mikkelsen TS, Giovinazzo H, Sparreboom A. Sprowl JA, et al. Drug Resist Updat. 2012 Feb-Apr;15(1-2):5-20. doi: 10.1016/j.drup.2012.01.009. Epub 2012 Mar 28. Drug Resist Updat. 2012. PMID: 22459901 Free PMC article. Review.

3

Polymorphic transporters and platinum pharmacodynamics.

Sprowl JA, Ness RA, Sparreboom A. Sprowl JA, et al. Drug Metab Pharmacokinet. 2013;28(1):19-27. doi: 10.2133/dmpk.dmpk-12-rv-073. Epub 2012 Sep 18. Drug Metab Pharmacokinet. 2013. PMID: 22986709 Free PMC article. Review.

4

Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.

Lancaster CS, Sprowl JA, Walker AL, Hu S, Gibson AA, Sparreboom A. Lancaster CS, et al. Among authors: sprowl ja. Mol Cancer Ther. 2013 Aug;12(8):1537-44. doi: 10.1158/1535-7163.MCT-12-0926. Epub 2013 Jun 11. Mol Cancer Ther. 2013. PMID: 23757163 Free PMC article.

5

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.

Sprowl JA, Ciarimboli G, Lancaster CS, Giovinazzo H, Gibson AA, Du G, Janke LJ, Cavaletti G, Shields AF, Sparreboom A. Sprowl JA, et al. Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11199-204. doi: 10.1073/pnas.1305321110. Epub 2013 Jun 17. Proc Natl Acad Sci U S A. 2013. PMID: 23776246 Free PMC article.

6

A phosphotyrosine switch regulates organic cation transporters.

Sprowl JA, Ong SS, Gibson AA, Hu S, Du G, Lin W, Li L, Bharill S, Ness RA, Stecula A, Offer SM, Diasio RB, Nies AT, Schwab M, Cavaletti G, Schlatter E, Ciarimboli G, Schellens JHM, Isacoff EY, Sali A, Chen T, Baker SD, Sparreboom A, Pabla N. Sprowl JA, et al. Nat Commun. 2016 Mar 16;7:10880. doi: 10.1038/ncomms10880. Nat Commun. 2016. PMID: 26979622 Free PMC article.

7

Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.

Hafey MJ, Aleksunes LM, Bridges CC, Brouwer KR, Chien HC, Leslie EM, Hu S, Li Y, Shen J, Sparreboom A, Sprowl J, Tweedie D, Lai Y. Hafey MJ, et al. Clin Pharmacol Ther. 2022 Sep;112(3):527-539. doi: 10.1002/cpt.2638. Epub 2022 Jun 10. Clin Pharmacol Ther. 2022. PMID: 35546260 Review.

8

Associations between ABCC2 polymorphisms and cisplatin disposition and efficacy.

Sprowl JA, Gregorc V, Lazzari C, Mathijssen RH, Loos WJ, Sparreboom A. Sprowl JA, et al. Clin Pharmacol Ther. 2012 Jun;91(6):1022-6. doi: 10.1038/clpt.2011.330. Clin Pharmacol Ther. 2012. PMID: 22534871 Free PMC article.

9

Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearance.

Sprowl JA, van Doorn L, Hu S, van Gerven L, de Bruijn P, Li L, Gibson AA, Mathijssen RH, Sparreboom A. Sprowl JA, et al. Clin Pharmacol Ther. 2013 Nov;94(5):585-92. doi: 10.1038/clpt.2013.145. Epub 2013 Jul 17. Clin Pharmacol Ther. 2013. PMID: 23863876 Free PMC article.

10

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.

Hu S, Leblanc AF, Gibson AA, Hong KW, Kim JY, Janke LJ, Li L, Vasilyeva A, Finkelstein DB, Sprowl JA, Sweet DH, Schlatter E, Ciarimboli G, Schellens J, Baker SD, Pabla N, Sparreboom A. Hu S, et al. Among authors: sprowl ja. Clin Transl Sci. 2017 Sep;10(5):412-420. doi: 10.1111/cts.12480. Epub 2017 Jul 8. Clin Transl Sci. 2017. PMID: 28689374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters